These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1337458)

  • 1. Reduction in cardiac conduction velocity delay by angiotensin converting enzyme inhibition in hypertensive patients with left ventricular hypertrophy. Detection by signal averaged electrocardiography.
    González-Fernández RA; Altieri PI; Fernández-Martínez J; Lugo JE
    Am J Hypertens; 1992 Dec; 5(12 Pt 1):896-9. PubMed ID: 1337458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of enalaprilat on hemodynamics and ventricular activation duration in hypertensive patients with left ventricular hypertrophy: clinical evidence of improved excitation-contraction coupling with angiotensin converting enzyme inhibition in human hypertension.
    González-Fernández RA; Altieri PI; Jiménez R; Lastra J; Meléndez JR; Martínez-Toro JA; Banchs HL
    Am J Hypertens; 1993 Jul; 6(7 Pt 1):570-8. PubMed ID: 8397997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution and functional significance of cardiac angiotensin converting enzyme in hypertrophied rat hearts.
    Schunkert H; Jackson B; Tang SS; Schoen FJ; Smits JF; Apstein CS; Lorell BH
    Circulation; 1993 Apr; 87(4):1328-39. PubMed ID: 8384939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracoronary angiotensin-converting enzyme inhibition improves diastolic function in patients with hypertensive left ventricular hypertrophy.
    Haber HL; Powers ER; Gimple LW; Wu CC; Subbiah K; Johnson WH; Feldman MD
    Circulation; 1994 Jun; 89(6):2616-25. PubMed ID: 8205673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diastolic properties in canine hypertensive left ventricular hypertrophy: effects of angiotensin converting enzyme inhibition and angiotensin II type-1 receptor blockade.
    Hayashida W; Donckier J; Van Mechelen H; Charlier AA; Pouleur H
    Cardiovasc Res; 1997 Jan; 33(1):54-62. PubMed ID: 9059528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regression of left ventricular hypertrophy results in improvement of QT dispersion in patients with hypertension.
    Karpanou EA; Vyssoulis GP; Psichogios A; Malakou C; Kyrozi EA; Cokkinos DV; Toutouzas PK
    Am Heart J; 1998 Nov; 136(5):765-8. PubMed ID: 9812069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial hemodynamic and renal effects of intravenous enalaprilat following coronary artery bypass surgery complicated by left ventricular dysfunction.
    Wagner F; Yeter R; Bisson S; Siniawski H; Hetzer R
    Crit Care Med; 2003 May; 31(5):1421-8. PubMed ID: 12771613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of enalaprilat on postoperative hypertension after surgical repair of coarctation of the aorta.
    Rouine-Rapp K; Mello DM; Hanley FL; Mohan Reddy V; Soifer S
    Pediatr Crit Care Med; 2003 Jul; 4(3):327-32. PubMed ID: 12831415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Arrhythmogenicity in left ventricular hypertrophy in mild to moderate arterial hypertension].
    Franchi F; Michelucci A; Padeletti L; Monopoli A; Fabbri G; Cersosimo RM; Mezzani A
    G Ital Cardiol; 1992 Aug; 22(8):905-18. PubMed ID: 1478391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stage-specific differential activation of mitogen-activated protein kinases in hypertrophied and failing rat hearts.
    Hayashida W; Kihara Y; Yasaka A; Inagaki K; Iwanaga Y; Sasayama S
    J Mol Cell Cardiol; 2001 Apr; 33(4):733-44. PubMed ID: 11273726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiparametric electrocardiographic evaluation of left ventricular hypertrophy in idiopathic and hypertensive cardiomyopathy.
    Lazzeri C; Barletta G; Badia T; Capalbio A; Del Bene R; Franchi F; Gensini GF; Michelucci A
    Ital Heart J; 2005 Apr; 6(4):304-10. PubMed ID: 15902928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of left ventricular hypertrophy in human hypertension.
    Kahan T
    J Hypertens Suppl; 1998 Sep; 16(7):S23-9. PubMed ID: 9855028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinaprilat-induced vasodilatation in forearm vasculature of patients with essential hypertension: comparison with enalaprilat.
    Houben AJ; Kroon AA; de Haan CH; Fuss-Lejeune MJ; de Leeuw PW
    Cardiovasc Drugs Ther; 2000 Dec; 14(6):657-63. PubMed ID: 11300367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enalaprilat decreases plasma endothelin and atrial natriuretic peptide levels and preload in patients with left ventricular dysfunction after cardiac surgery.
    Tohmo H; Karanko M; Klossner J; Scheinin M; Viinamäki O; Neuvonen P; Ruskoaho H
    J Cardiothorac Vasc Anesth; 1997 Aug; 11(5):585-90. PubMed ID: 9263090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dynamics of left ventricular longitudinal function in patients with arterial hypertension during therapy with angiotensin converting enzyme inhibitor moexipril].
    Pavliukova EN; Bakhmet'eva TA; Puzyrev KV; Karpov RS
    Kardiologiia; 2006; 46(9):19-25. PubMed ID: 17047618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic infusion of enalaprilat into hypothalamic paraventricular nucleus attenuates angiotensin II-induced hypertension and cardiac hypertrophy by restoring neurotransmitters and cytokines.
    Kang YM; Zhang DM; Yu XJ; Yang Q; Qi J; Su Q; Suo YP; Yue LY; Zhu GQ; Qin DN
    Toxicol Appl Pharmacol; 2014 Feb; 274(3):436-44. PubMed ID: 24342267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous i.v. administration of the angiotensin-converting enzyme inhibitor enalaprilat in the critically ill: effects on regulators of circulatory homeostasis.
    Boldt J; Menges T; Wollbrück M; Härter K; Hempelmann G
    J Cardiovasc Pharmacol; 1995 Mar; 25(3):416-23. PubMed ID: 7769807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of SERCA2a following short-term ACE inhibition (by enalaprilat) alters contractile performance and arrhythmogenicity of healthy myocardium in rat.
    Matus M; Kucerova D; Kruzliak P; Adameova A; Doka G; Turcekova K; Kmecova J; Kyselovic J; Krenek P; Kirchhefer U; Mueller FU; Boknik P; Klimas J
    Mol Cell Biochem; 2015 May; 403(1-2):199-208. PubMed ID: 25663023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Arrhythmia risk and noninvasive markers in hypertensive left ventricular hypertrophy].
    Akdeniz B; Güneri S; Badak O; Aslan O; Tamci B
    Anadolu Kardiyol Derg; 2002 Jun; 2(2):121-9; AXVII. PubMed ID: 12134537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.